Efficacy of Adding Sitagliptin or Pioglitazone to Patients With Type 2 Diabetes Insufficiently Controlled With Metformin and Sulfonylurea.
Phase of Trial: Phase IV
Latest Information Update: 09 Oct 2012
At a glance
- Drugs Pioglitazone; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms JAS
- 10 Jun 2017 Biomarkers information updated
- 09 Oct 2012 Last checked against ClinicalTrials.gov record.
- 09 Oct 2012 Primary endpoints amended as reported by ClinicalTrials.gov.